These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 9493698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle.
    Kitada Y, Morita M, Narimatsu A.
    Jpn J Pharmacol; 1989 Aug; 50(4):411-9. PubMed ID: 2789299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?
    Kitada Y, Narimatsu A, Matsumura N, Endo M.
    Eur J Pharmacol; 1987 Feb 10; 134(2):229-31. PubMed ID: 3569412
    [Abstract] [Full Text] [Related]

  • 6. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats.
    Ming MJ, Hu D, Chen HS, Liu LM, Nan X, Hua CH, Lu RQ.
    Shock; 2000 Dec 10; 14(6):652-6. PubMed ID: 11131917
    [Abstract] [Full Text] [Related]

  • 7. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.
    Kitada Y, Narimatsu A, Matsumura N, Endo M.
    J Pharmacol Exp Ther; 1987 Nov 10; 243(2):633-8. PubMed ID: 3500301
    [Abstract] [Full Text] [Related]

  • 8. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity.
    Hattori Y, Ishitani T, Tomita F, Gando S, Yokoshiki H, Azuma M, Kemmotsu O, Kanno M.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov 10; 360(5):585-90. PubMed ID: 10598798
    [Abstract] [Full Text] [Related]

  • 9. Restoration of ischemic contractile failure of indo-1-loaded guinea pig heart by a calcium sensitizer, MCI-154.
    Abe Y, Sekioka K, Ishisu R, Onishi K, Ueda Y, Nakano T.
    J Pharmacol Exp Ther; 1996 Oct 10; 279(1):47-55. PubMed ID: 8858974
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of the effects of MCI-154, a novel cardiotonic agent, on cardiac tissues.
    Narimatsu A, Kitada Y, Satoh N, Morita M, Muroyama A, Kobayashi M, Ohizumi Y.
    Jpn J Pharmacol; 1989 Mar 10; 49(3):397-405. PubMed ID: 2545964
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
    Kitada Y, Kobayashi M, Narimatsu A, Ohizumi Y.
    J Pharmacol Exp Ther; 1989 Jul 10; 250(1):272-7. PubMed ID: 2545860
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of early contractile failure during hypoxia in intact ferret heart: evidence for modulation of maximal Ca2+-activated force by inorganic phosphate.
    Kusuoka H, Weisfeldt ML, Zweier JL, Jacobus WE, Marban E.
    Circ Res; 1986 Sep 10; 59(3):270-82. PubMed ID: 2429780
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    Abe Y, Kitada Y, Narimatsu A.
    J Pharmacol Exp Ther; 1992 Jun 10; 261(3):1087-95. PubMed ID: 1602375
    [Abstract] [Full Text] [Related]

  • 17. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ.
    Circ Res; 1995 Jul 10; 77(1):107-13. PubMed ID: 7788868
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H, Kaheinen P, Levijoki J, Lindén IB.
    Cardiovasc Res; 1997 Jun 10; 34(3):536-46. PubMed ID: 9231037
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.